December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Effect of Combined Cytotoxic Therapy on Cell Proliferation, RNA-Synthesis and Apoptosis
Author Affiliations & Notes
  • GR Welsandt
    Department of Ophthalmology University of Cologne Cologne Germany
  • A Hueber
    Cologne Germany
  • N Kociok
    Cologne Germany
  • P Esser
    Cologne Germany
  • GK Krieglstein
    Cologne Germany
  • H Mietz
    Cologne Germany
  • Footnotes
    Commercial Relationships   G.R. Welsandt, None; A. Hueber, None; N. Kociok, None; P. Esser, None; G.K. Krieglstein, None; H. Mietz, None. Grant Identification: DFG Mi347/5-1,Es82/5-2,Jo324/4-1,Köln Fortune
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 869. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      GR Welsandt, A Hueber, N Kociok, P Esser, GK Krieglstein, H Mietz; Effect of Combined Cytotoxic Therapy on Cell Proliferation, RNA-Synthesis and Apoptosis . Invest. Ophthalmol. Vis. Sci. 2002;43(13):869.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Enhancement of glaucomatous filtering procedures by the use of antimetabolites is associated with toxic side-effects which are related to the amount and concentration of the specific drug used. Currently, only single drugs, mostly 5-Fluorouracil and Mitomycin, are used clinically. We performed human Tenon´s fibroblast cell culture studies to assess how the combination of two synergistic acting cytotoxic drugs possibly influence cell migration, RNA-synthesis and apoptosis. The aim was to reduce the toxic side effects of these drugs by achieving a similar strong antiproliferative effect as compared to the use of mitomycin or 5-fluorouracil. Methods: Cell proliferation was assessed by use of the scratch assay (Grisanti et al, 1998). With this technique, it was determined how much cells can proliferate two-dimensionally under standard conditions within a specific time period. RNA synthesis was measured with the (5,6-3H) uridine incorporation assay. Cells were pulse-labeled for 1h with 0.5µCi/ml (5,6-3H) uridine, and cell lysates were counted in a liquid scintillation counter. Experiments were performed in triplicate. Apoptosis was determined with the TUNEL assay using the cultured fibroblasts. Results: Proliferation was significantly inhibited by all combinations used in our studies. The strongest effect was observed with the combination of lomustin and fas-ligand (1.1±16.0% of proliferation), while the other combinations such as staurosporin and mitomycin (12.8±5.3%), staurosporin and doxorubicin (11.5±11.1%) or staurosporin and lomustin (19.2±4.8%) had less strong effects. RNA-synthesis was significantly inhibited by all combinations tested. Inhibition found included lomustin and fas-ligand (10.4%), staurosporin and mitomycin (81.7%), staurosporin and doxorubicin (28.7%) or staurosporin and lomustin (84.6%). The strongest inhibition was detected with the combination of staurosporin and vincristin (86.4%). TUNEL positive cells were observed with all combinations used here to a variable extent exceeding a proportion of 50% in most combinations tested. Conclusion: These results suggest that the use of single substances to inhibit postoperative scarring following glaucomatous filtering procedures can be substituted by combinations of cytotoxic drugs. Interestingly, it appears that specific combinations have variable strong effects on cell proliferation and RNA-synthesis, so that it remains to be determined which of these effects has the largest impact clinically.

Keywords: 341 cell death/apoptosis • 523 proliferation • 631 wound healing 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×